NovaResp Technologies
Halifax
About NovaResp Technologies
NovaResp Technologies offers artificial intelligence and personalized therapy to obstructive sleep apnea patients. They use medical technology to predict and prevent obstructive sleep apnea. They provide cMAP technology, which can be installed on any positive airway pressure machine and is primarily used to predict and prevent respiratory events.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $6.8M
- Funding stage: Seed
- Last round: Seed (May 2024)
- Website: novaresp.com
Industries & Categories
Artificial Intelligence (AI), Health Care
Social Profiles
Canonical: https://fsome.com/organization/novaresp-technologies-10558 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.